Global Bioburden Testing Market to Grow at 10.83% During 2024-2032, Spurred by Rapid Outbreak of COVID-19

April 22, 2021 | Healthcare

According to the latest report by IMARC Group, titled "Bioburden Testing Market Report by Product (Consumables, Instruments), Test Type (Aerobic Count Testing, Anaerobic Count Testing, Fungi/Mold Count Testing, Spores Count Testing, and Others), Application (Raw Material Testing, Medical Devices Testing, In-process Testing, Sterilization Validation Testing, and Others), End User (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Contract Manufacturing Organizations (CMOs), Food and Beverages Companies, and Others), and Region 2024-2032," the global bioburden testing market is expected to grow at a CAGR of 10.83% during 2024-2032. Bioburden testing refers to the study of measuring viable microorganism count on or in a product. It is essential for the sterilization process to ensure the safety and effectiveness of medical devices. It is utilized for the assessment of cleaning processes by analyzing the amounts and different types of microorganisms found in sterile devices throughout the production process. It can also be employed for routine monitoring of components and raw materials and during the assembly of parts in the manufacturing process. Apart from this, it can also be used for testing the contamination levels in pharmaceutical products and food and beverages.

Global Bioburden Testing Market Trends:

The global market is primarily driven by the increasing demand for efficient safety testing tools in the healthcare sector. This has impelled numerous players to invest in high-quality bioburden testing to achieve enhanced sterility assurance. Moreover, governments of numerous countries are issuing stringent guidelines and microbial contamination prevention strategies to ensure improved sterilization processes during the manufacturing of medical devices. Coupled with the rising need for bioburden testing to be performed on devices for routine quality control processes, this is expected to create a positive outlook for the market. The market is further driven by the rapid outbreak of coronavirus disease (COVID-19) across the globe and the escalating need for sterilizing medical equipment at frequent intervals amid healthcare settings. Also, the strict food safety standards in the food and beverages sector have led to the growing need for microbiological bioburden testing on the global level.

Market Summary:

  • Based on the product, the market has been bifurcated into consumables (culture media, reagents and others) and instruments (automated microbial identification systems, polymerase chain reaction systems, microscopes, and others).
  • On the basis of the test type, the market has been divided into aerobic count testing, anaerobic count testing, fungi/mold count testing, spores count testing and others.
  • Based on the application, the market has been classified into raw material testing, medical devices testing, in-process testing, sterilization validation testing, and others.
  • On the basis of the end user, the market has been categorized into pharmaceutical and biotechnology companies, medical device companies, contract manufacturing organizations (CMOs), food and beverages companies, and others.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Becton Dickinson and Company, Biomérieux SA (Compagnie Merieux Alliance), Charles River Laboratories Inc, Merck KGaA, Nelson Laboratories LLC (Sotera Health LLC), North American Science Associates Inc., Pacific BioLabs Inc., SGS SA, Thermo Fisher Scientific Inc and Wuxi Apptec.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Test Type, Application, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Becton Dickinson and Company, Biomérieux SA (Compagnie Merieux Alliance), Charles River Laboratories Inc, Merck KGaA, Nelson Laboratories LLC (Sotera Health LLC), North American Science Associates Inc., Pacific BioLabs Inc., SGS SA, Thermo Fisher Scientific Inc and Wuxi Apptec
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Bioburden Testing Market to Grow at 10.83% During 2024-2032, Spurred by Rapid Outbreak of COVID-19
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More